Imunon, Inc. Income Taxes Receivable, Current
Imunon, Inc. (IMNN) had Income Taxes Receivable, Current of $0 as of 2011-12-31, per its 10-K/A filed 2012-03-15.
Discontinued › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2012-03-15
- 2011-12-31: Income Taxes Receivable, Current $0.00.
- 2010-12-31: Income Taxes Receivable, Current $0.00.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2011-12-31 | $0.00 10-K/A · filed 2012-03-15 |
| 2010-12-31 | $0.00 10-K/A · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |